Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Percutaneous Coronary Intervention
75%
Transcatheter Aortic Valve Replacement
53%
Taxus
46%
Paclitaxel-eluting Stent
39%
ARRIVE
36%
Stent Thrombosis
33%
Clinical Outcomes
33%
Stent
25%
Myocardial Infarction
25%
Adverse Cardiac Events
23%
Drug-eluting Stent
23%
Target Lesion Revascularization
23%
High Risk
22%
Coronary Stent
19%
Perimembranous Ventricular Septal Defect
18%
Transcatheter Closure
18%
Mitral Regurgitation
17%
Surgical Aortic Valve Replacement
17%
United States
17%
Balloon
15%
Patent Foramen Ovale
15%
2-year Outcome
15%
In-stent Restenosis
15%
Amplatzer
15%
Revascularization
13%
Cardiogenic Shock
13%
Severe Aortic Stenosis
13%
Percutaneous Repair
12%
Delayed Revascularization
12%
Fractional Flow Reserve
12%
Coronary Bifurcation Lesions
12%
Restenosis
12%
Acute Coronary Syndrome
11%
Clinical High Risk
11%
Randomized Trial
11%
Aortic Stenosis
11%
Confidence Interval
11%
Transcatheter
11%
Aortic Valve Replacement
11%
Paclitaxel
11%
Left Atrium
10%
Muscular Ventricular Septal Defect
10%
Pseudoaneurysm
10%
Patient Demographics
10%
Randomized Controlled Trial
10%
Intracoronary Stenting
10%
Ostial Lesion
10%
Long-term Clinical Outcome
9%
Multivessel
9%
Randomized Comparison
9%
Medicine and Dentistry
Percutaneous Coronary Intervention
100%
Percutaneous Aortic Valve Replacement
53%
Paclitaxel
43%
Stenting
41%
Stent Thrombosis
33%
Drug-Eluting Stent
31%
Myocardial Infarction
31%
Aortic Stenosis
25%
Revascularization
24%
Target Lesion Revascularization
23%
Patent Foramen Ovale
22%
Mitral Insufficiency
21%
Ventricular Septal Defect
21%
Cardiovascular System
18%
In-Stent Restenosis
18%
Coronary Artery Disease
17%
Infarction
16%
Cardiogenic Shock
16%
Aortic Valve Replacement
15%
Health Care Cost
15%
Pseudoaneurysm
14%
Restenosis
13%
Hemodynamic
13%
Randomized Controlled Trial
13%
Atrial Septal Defect
12%
Fractional Flow Reserve
12%
Coronary Bifurcation Lesion
12%
Acute Coronary Syndrome
12%
Assisted Circulation
12%
Surgeon
11%
Combination Therapy
10%
Mortality Rate
10%
Cardiac Catheterization
10%
Transluminal Coronary Angioplasty
10%
Left Atrium
10%
Ventricular Assist Device
9%
Patient Population
9%
Comorbidity
9%
Rapamycin
8%
Heart Disease
8%
Laser Angioplasty
8%
Coronary Artery Obstruction
8%
Coronary Artery Dissection
8%
Valve Replacement
8%
Intravascular Ultrasound
8%
Persistent Truncus Arteriosus
8%
Brachytherapy
8%
Mitral Valve
8%
Odds Ratio
8%
Diabetes Mellitus
8%
